CDKN2A and cervical squamous cell carcinoma: p16INK4a is a cyclin-dependent kinase inhibitor that decelerates the cell cycle and functions as a tumor-suppressor gene [34] in many human cancers, in contrast, overexpression of p16INK4a in the nucleus and the cytoplasm strongly correlates with cancer progression in cervical squamous cell carcinomas [35,36].